To maintain liposomaleffect, avoid exposing to heat or freezing temperatures
Finally, we found a similar decrease in survival when treating CCNE1-driven cells with PARP inhibitors that have less PARP-trapping activity than olaparib (Extended Data Fig
Every intervention has tradeoffs, and you deserve to know exactly what they are
Studies have indicated that 47% of cirrhosis patients endure sleep disturbances, while 69% experience both disturbed sleep and depression
A personalized, clinically guided program designed to help you reach sustainable goals while improving metabolic health and confidence through advanced medical weight loss solutions
A 2024 Guidelines Update FEATURING Alyssa Lampe Dominguez 2,341 views October 21, 2024 20 John La Puma The GLP-1 Playbook and Essence 1,539 views April 11, 2025 18 Brian Wojeck Update on Obesity Pharmacotherapy 1,595 views December 23, 2024 18 Scripps Health Primary Care Literature Update: 2022/2023 FEATURING Joel Diamant 1,061 views September 12, 2023 18 Holly Wyatt Myths of Obesity Care: Health at Almost Every Size